SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biota -- Ignore unavailable to you. Want to Upgrade?


To: Angelo Ferraro who wrote (40)10/6/1999 8:28:00 PM
From: A.J. Mullen  Respond to of 46
 
I interpreted the fears concerning the impact of Relenza as bullish - if the costs were going to affect the British NHS, they must be expecting big sales. It seems the British Govt is dissuading doctors from prescribing it, which is, i agree not bullish.

Now Gilead's been approved for the same season as Relenza. Thanks for the news. Good for mankind, not so good for my finances.